Insider Transactions in Q4 2025 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 08
2025
|
Todd Anderman Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,132
-11.28%
|
$133,584
$12.34 P/Share
|
|
Oct 02
2025
|
Jeffrey S. Heier Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,502
-4.04%
|
$115,522
$11.04 P/Share
|
|
Oct 02
2025
|
Peter Kaiser Chief Development Officer |
SELL
Open market or private sale
|
Direct |
9,653
-4.73%
|
$106,183
$11.03 P/Share
|